- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03293056
HIIH Versus HMC: Randomized Clinical Trial (HIITxHMC)
May 9, 2023 updated by: Rodrigo Gustavo da Silva Carvalho, Universidade Federal do vale do São Francisco
Effectiveness of High-intensity Interval Versus Intensity Continuous Hydrogymnastics for Improvement of Health Outcomes: Randomized Clinical Trial.
Introduction: water aerobics involves the practice of specific aquatic exercises that are based on the use of water resistance as a load and on thrust as an impact reducer, making it possible to perform physical exercise with a lower risk of injury even at a high intensity.
Objective: The overall objective of this study will be to compare the effectiveness of high intensity interval versus moderate continuous water aerobics to improve health outcomes in apparently healthy individuals.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Method: randomized clinical trial will be performed in the premises of the College of Physical Education of the Federal University of the São Francisco Valley.
100 adults, of both sexes, will be randomized into two groups, high intensity interval hydrogynastic (HIAI) or moderate continuous aquatic gymnastics (HCM).
Individuals will be evaluated for primary endpoints of muscle strength and endurance, aerobic fitness, flexibility and body composition.
The secondary outcomes evaluated will be the quality of life, functionality and perception of improvement by a Likert-type Improvement Scale, at the following moments: initial, final and follow-up of one month after the end of the training.
Individuals will be assisted for three months, often weekly twice, with sessions lasting 50 min.
In order to identify differences between and within the groups, an equation of generalized estimates will be used as regression model with the syntax according to the multivariate model.
Study Type
Interventional
Enrollment (Anticipated)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rodrigo GS Carvalho, PhD
- Phone Number: 8721016856
- Email: rodrigo.carvalho@univasf.edu.br
Study Locations
-
-
Pernambuco
-
Petrolina, Pernambuco, Brazil, 56304917
- Recruiting
- Physical Education College
-
Contact:
- Rodrigo GS Carvalho, PhD
- Phone Number: 8721016856
- Email: rodrigo.carvalho@univasf.edu.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- age between 18 and 60 years;
- sedentary and who did not perform physiotherapy and physical activity in the last three months;
- clinical and cognitive conditions for swimming pool activities and aerobic exercise; who have not undergone highly complex surgical procedures in the last six months;
- to be able of walking without help equipment and without musculoskeletal or skeletal diseases;
- without contraindications to the practice of exercises; such as: urinary and / or fecal incontinence and dermatological diseases;
- below obesity II with BMI <40.
Exclusion Criteria:
- if they have up to three consecutive fouls during the hydrogymnastics period;
- if they present any adverse effects, such as: allergy or any dermatitis;
- unable to continue the study due to change of address or hospitalization.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-intensity Interval Hydrogynmastics
High-intensity Interval training Hydrogynmastics, 2x/week, for 3 months.
|
The HIIH to PSE group during the high intensity (HI) period should remain between 16 to 18 points, while in the moderate intensity (MI) intervals around 11.
The dynamic exercises will progression, in the first month will be 1 min of HI and 2 min of MI, in the second month of 1 min of HI and 1 min of MI and in the last month of 1 min of HI and 30 s of MI, until completing 30 min in total.
Other Names:
|
Active Comparator: Hydrogynmastics Continuous Moderate
Hydrogynmastics Continuous Moderate training (HCM), 2x/week, for 3 months.
|
For the HCM group the PSE will be around 11 points during the 30 min of moderate continuous exercise.
In both groups the form of intensity monitoring that will be through the PSE, in which this scale will be printed in banner form and affixed next to the physical education teacher during the classes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aerobic Fitness
Time Frame: three months after randomization
|
This maximal/submaximal test will be performed on cyclergometer, Balke test.
|
three months after randomization
|
Body Composition
Time Frame: three months after randomization
|
The body composition (density and percentage of body fat) will be estimated by prediction equations (JACKSON et al., 1980).
|
three months after randomization
|
Strength Muscular
Time Frame: three months after randomization
|
Strength Muscular will be measured by 1RM test in two exercises, involving the segments of the upper limbs (supine) and lower limbs (leg press).
|
three months after randomization
|
Endurance Muscular
Time Frame: three months after randomization
|
Muscle endurance will be assessed by the test in which the individual performs the maximum number of repetitions of given exercises for one minute.
The exercises will be of arm and abdominal flexion.
|
three months after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functionality
Time Frame: three months after randomization
|
Functionality will be assessed by IVCF-20
|
three months after randomization
|
Perception of Improvement
Time Frame: three months after randomization
|
Perception of Improvement will be measured by an Likert-type Improvement Scale
|
three months after randomization
|
Quality Life
Time Frame: three months after randomization
|
Quality of life by assessed by WHOQOL-breaf
|
three months after randomization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
September 21, 2017
First Submitted That Met QC Criteria
September 21, 2017
First Posted (Actual)
September 26, 2017
Study Record Updates
Last Update Posted (Estimate)
May 11, 2023
Last Update Submitted That Met QC Criteria
May 9, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 012017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy People
-
HES-SO Valais-WallisEnrolling by invitationHealthy PeopleSwitzerland
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Universidad Católica del MauleCompleted
-
Acibadem UniversityMarmara UniversityCompletedHealthy Young PeopleTurkey
-
Marmara UniversityCompleted
-
Hacettepe UniversityCompleted
-
Centre National de la Recherche Scientifique, FranceInstitut National de la Santé Et de la Recherche Médicale, France; Sorbonne... and other collaboratorsUnknown
-
Kaohsiung Medical University Chung-Ho Memorial...Unknown
Clinical Trials on High-intensity interval Hydrogynmastics
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Laboratoire des Adaptations Métaboliques à l'Exercice...CREPS Auvergne Rhône-Alpes / VichyCompletedOverweight | PostmenopausalFrance
-
Université de SherbrookeRecruiting
-
Riphah International UniversityCompleted